Duramune Adult C3 (3yr)
This is a prescription medicine. A prescription is required from your veterinarian before we can supply this product. Please ensure that you have read the "How to Order" page before ordering this item.
We apologise that we are unable to display a photograph of the packaging or provide you with more information regarding this prescription medicine. Australian legislation prohibits the advertisement of prescription drugs to consumers.
All of our products are APVMA or TGA approved and identical to those used by your veterinarian. Please call or email us if you have any queries about any of the products on our site.
|Drug Name and Strength||Live attenuated canine distemper virus, live attenuated canine adenovirus type 2 (infectious hepatitis), live attenuated canine parvovirus|
|Indication||Immunisation of healthy dogs, 6 weeks of age or older to protect against disease caused by canine distemper virus, canine adenovirus type 1, canine adenovirus type 2 and canine parvovirus. This vaccine provides cross-protection against CPV-2a, CPV-2b, and CPV-2c. This vaccine prevents viral shedding caused by canine parvovirus infection. Early protection of puppies with final vaccination from 10 weeks.|
|Precautions||Vaccinate only healthy dogs with normal temperatures. Dogs under treatment with immunosuppressive drugs should not be vaccinated. The use of this vaccine in pregnant bitches is not recommended.First Aid If poisoning occurs, contact a doctor or Poisons Information Centre. Phone Australia 131 126. Take care to avoid self-injection. In the event of self-administration, seek medical attention if you are concerned and show the package leaflet or the label to the medical practitioner.|
|Dosage and Administration||Recommended vaccination programs. In any population of dogs a very small proportion may fail to adequately respond to vaccination due to concurrent illness, stress, immunosuppression, genetic factors or the presence of maternal antibodies. The epidemiology of each disease, the likely persistence of maternal antibodies and the dog's history and environment should be considered when deciding on a suitable vaccination program for a particular animal. Reconstitute the freeze dried vaccine with sterile water for injection (1 mL), Protech C2i, Protech Pi2 reconstituted with Protech BB or alternatively, the Virbac inactivated Bordetella and parainfluenza vaccine may be used as a diluent for Duramune Adult C3 vaccine. Inject subcutaneously within 20 minutes of reconstitution. A new sterile syringe and needle should always be used to administer this vaccine. Do not use chemicals or disinfectants to sterilise the skin, needles or syringes.Primary vaccination programs. Puppies < 10 weeks of age. Vaccination of puppies with Duramune Adult C3 at 6, 8 and 10 weeks is highly recommended to maximise protection. Where puppies present for their first vaccination at 8 weeks of age, a second vaccination at 10 weeks is recommended. Vaccination according to these programs provides three years' protection against diseases caused by canine distemper virus, canine adenovirus types 1 and 2 and canine parvovirus. Puppies and dogs 10 weeks of age or older. One dose of Duramune Adult C3. In previously unvaccinated dogs of 10 weeks of age or older, a single dose of Duramune Adult C3 is sufficient to confer three years' protection against disease caused by canine distemper virus, canine adenovirus type 1, canine adenovirus type 2 and canine parvovirus. However, to ensure optimal cover, it is highly recommended that a vaccination program be instituted at an earlier age as described above. Protech C2i may be used as a diluent for Duramune Adult C3. Two doses two to four weeks apart will protect against Leptospira interrogans serovar Copenhageni and canine coronavirus.Revaccination. Duramune Adult C3 has been demonstrated to provide three years' protection against disease caused by canine distemper virus, canine adenovirus type 1, canine adenovirus type 2 and canine parvovirus. The vaccine may therefore be included in programs of revaccination intervals of three years following the primary vaccination program. The vaccine may also be used for shorter revaccination intervals if desired. For instance, a common international practice is for dogs to receive their first revaccination at 12 months after the primary puppy vaccination and at three year intervals thereafter.For protection against canine parainfluenza virus and Bordetella bronchiseptica , annual revaccination with Protech Bronchi-Shield III or Protech Bronchi-Shield Oral and Protech Pi2 is recommended. Annual revaccination against canine coronavirus and Leptospira interrogans serovar Copenhageni is recommended using Protech C2i vaccine.Suggested vaccination programs. 6 weeks. Duramune Adult C3 + Protech C2i. 8 weeks. Duramune Adult C3 + Protech C2i and Protech Bronchi-Shield III. 10 weeks. Duramune Adult C3. 14 months.* Protech Bronchi-Shield III and Protech C2i. 2 years. Protech Bronchi-Shield III and Protech C2i. 3 years. Duramune Adult C3 + Protech C2i and Protech Bronchi-Shield III. Continue annual and triennial protocols as listed above.*Optional vaccination with Duramune Adult C3 at 14 months of age (12 months following puppy vaccination) and at three year intervals thereafter.|
|Storage||Store at 2 to 8°C. (Refrigerate. Do not freeze.) Protect from light.|
|MSDS (external link)||Duramune Adult C3 (3yr) MSDS|
|Label (external link)||Duramune Adult C3 (3yr) Label|
|Manufacturer||Boehringer Ingelheim Animal Health Australia Pty Ltd|